Detection of Enterovirus RNA in Atheromatous Lesions (ATH-ENTE)
Primary Purpose
Arteriosclerosis
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Artery resection
Sponsored by
About this trial
This is an interventional basic science trial for Arteriosclerosis focused on measuring Arteriosclerosis, Arterial Occlusive Diseases, Enterovirus, Artery resection
Eligibility Criteria
Inclusion Criteria:
- Indication of artery resection
- affiliated or a beneficiary of a social security category
- having signed the inform consent form
Exclusion Criteria:
- pregnant women
- contra-indication to clamping
- scheduled resection at friday after-noon, week-end or legal holidays
Sites / Locations
- CHU de Clermont-Ferrand
- CHU de Grenoble
- CHU de Saint-Etienne
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
1
Arm Description
Enterovirus RNA analysis
Outcomes
Primary Outcome Measures
Prévalence of detection of enteroviral RNA by RT-PCR in atherosclerotic carotid artery in comparison with sound carotid artery
Secondary Outcome Measures
Prevalence of detection of enteroviral RNA by RT-PCR in atherosclerotic carotid artery in comparison with sound vein
Prevalence of detection of enteroviral RNA by RT-PCR in sound carotid artery in comparison with sound vein
Prevalence of detection of enteroviral RNA by RT-PCR in calm and active atherosclerotic lesions
Prevalence of detection of antibodies between different groups of patients.
Prevalence of detection of enteroviral RNA by RT-PCR in atherosclerotic carotid artery in comparison with circulating blood
Full Information
NCT ID
NCT00674531
First Posted
May 7, 2008
Last Updated
October 8, 2014
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Ministry of Health, France
1. Study Identification
Unique Protocol Identification Number
NCT00674531
Brief Title
Detection of Enterovirus RNA in Atheromatous Lesions
Acronym
ATH-ENTE
Official Title
Detection of Enterovirus RNA by RT-PCR in Atheromatous Lesions
Study Type
Interventional
2. Study Status
Record Verification Date
October 2014
Overall Recruitment Status
Completed
Study Start Date
January 2008 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Ministry of Health, France
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Atherosclerosis is one of the first causes of morbidity-mortality in industrialized countries. Numerous works suggest that some infectious agents could be involved in the inflammatory process leading to the development of this pathology, such as Chlamydophila pneumoniae, cytomegalovirus or herpes simplex virus. Enteroviruses are small RNA viruses that have been incriminated in various acute or chronic cardiac diseases (pericarditis, myocarditis, dilated cardiomyopathy) and exhibit a tropism for vascular endothelia. Different clinical and experimental arguments suggest that they could play a cofactor role in the occurrence or maintenance of atherosclerosis lesions. A multicenter study developed in collaboration with colleagues of the University Hospital of Reims (France) showed that it was frequent to detect enterovirus RNA in cardiac biopsies from patients with myocardial infarction. Furthermore, a pilot study conducted in the University Hospital of Saint-Etienne (France) on atheromatous arterial samples from 18 patients allowed the detection of enterovirus RNA in 20% of them.
Detailed Description
Objective: In order to complete these data and to answer clearly to the question of the role of persistent infection by enteroviruses in atherosclerosis, we propose this research program involving the Departments of Vascular Surgery of three University hospitals of the "Rhône-Alpes" region and of three laboratories of Virology interested by the relationship between chronic diseases and enterovirus infection..
Methods: It is projected to include about one hundred voluntary adults exhibiting carotid atheromatous lesions requiring a surgical removal. Because of the difficulty to define a pertinent control group, each patient will be his/her own control. In addition to the fragment of pathologic carotid, it will be taken arterial and venous fragments from vessels that are never the seat of atherosclerosis lesions. To reach the best sensitivity, enterovirus RNA will be detected by nested RT-PCR.
Evaluation criteria: The main evaluation criterion will be the percentage of detection of enterovirus RNA by RT-PCR in atheromatous lesions by comparison to control arteries by Mac-Nemar test. These results will be correlated to anatomic and histological lesions of the atheromatous plaques. Other markers will be analysed secondarily: detection of enterovirus RNA in control venous samples, detection of stigmata of viral replication by immunochemistry or detection of negative RNA strands, analysis of the antibody response to enterovirus in blood, molecular typing of enteroviruses detected in the lesions… Expected benefits: This study should allow to better understand the putative involvement of enteroviruses in atherosclerosis-linked diseases. If the hypothesis of a relationship was confirmed, a more ambitious research project would be proposed in order to investigate the mechanisms by which enterovirus can favour atherosclerosis and to discuss the opportunity of preventive strategies (notably vaccination) to reduce the risk.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arteriosclerosis
Keywords
Arteriosclerosis, Arterial Occlusive Diseases, Enterovirus, Artery resection
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Other
Arm Description
Enterovirus RNA analysis
Intervention Type
Procedure
Intervention Name(s)
Artery resection
Intervention Description
Artery resection
Primary Outcome Measure Information:
Title
Prévalence of detection of enteroviral RNA by RT-PCR in atherosclerotic carotid artery in comparison with sound carotid artery
Time Frame
artery resection
Secondary Outcome Measure Information:
Title
Prevalence of detection of enteroviral RNA by RT-PCR in atherosclerotic carotid artery in comparison with sound vein
Time Frame
Artery resection
Title
Prevalence of detection of enteroviral RNA by RT-PCR in sound carotid artery in comparison with sound vein
Time Frame
Artery resection
Title
Prevalence of detection of enteroviral RNA by RT-PCR in calm and active atherosclerotic lesions
Time Frame
Artery resection
Title
Prevalence of detection of antibodies between different groups of patients.
Time Frame
Artery resection
Title
Prevalence of detection of enteroviral RNA by RT-PCR in atherosclerotic carotid artery in comparison with circulating blood
Time Frame
Artery resection
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Indication of artery resection
affiliated or a beneficiary of a social security category
having signed the inform consent form
Exclusion Criteria:
pregnant women
contra-indication to clamping
scheduled resection at friday after-noon, week-end or legal holidays
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Xavier BARRAL, MD PhD
Organizational Affiliation
CHU de Saint-Etienne
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Clermont-Ferrand
City
Clermont-ferrand
ZIP/Postal Code
63000
Country
France
Facility Name
CHU de Grenoble
City
Grenoble
ZIP/Postal Code
38000
Country
France
Facility Name
CHU de Saint-Etienne
City
Saint-etienne
ZIP/Postal Code
42055
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
17499019
Citation
Schanen C, Nasri D, Bourlet T, Barral X, Favre JP, Bourrat D, Peoc'h M, Ginevra C, Andreoletti L, Pozzetto B, Pillet S. Enterovirus in arteriosclerosis: a pilot study. J Clin Virol. 2007 Jun;39(2):106-12. doi: 10.1016/j.jcv.2007.03.014. Epub 2007 May 10.
Results Reference
background
PubMed Identifier
18061067
Citation
Andreoletti L, Venteo L, Douche-Aourik F, Canas F, Lorin de la Grandmaison G, Jacques J, Moret H, Jovenin N, Mosnier JF, Matta M, Duband S, Pluot M, Pozzetto B, Bourlet T. Active Coxsackieviral B infection is associated with disruption of dystrophin in endomyocardial tissue of patients who died suddenly of acute myocardial infarction. J Am Coll Cardiol. 2007 Dec 4;50(23):2207-14. doi: 10.1016/j.jacc.2007.07.080. Epub 2007 Nov 19.
Results Reference
background
Learn more about this trial
Detection of Enterovirus RNA in Atheromatous Lesions
We'll reach out to this number within 24 hrs